Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Capparelli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Pigment Cell & Melanoma Research|May 8, 2019
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated mannerDan A Erkes, Conroy O Field, Claudia Capparelli, et al.
Cell Cycle (Georgetown, Tex.)|June 12, 2012
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growthClaudia Capparelli, Diana Whitaker-Menezes, Carmela Guido, et al.
Cancer Research|August 18, 2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS MelanomaClaudia Capparelli, Timothy J Purwin, Shea A Heilman, et al.
Cell Cycle (Georgetown, Tex.)|September 1, 2012
CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesisClaudia Capparelli, Barbara Chiavarina, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|August 10, 2012
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate productionCarmela Guido, Diana Whitaker-Menezes, Claudia Capparelli, et al.
Molecular Cancer Therapeutics|June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant MelanomaMcKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Cell Cycle (Georgetown, Tex.)|December 2, 2011
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connectionRenee M Balliet, Claudia Capparelli, Carmela Guido, et al.
Cancer Research|July 25, 2015
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous MelanomasClaudia Capparelli, Sheera Rosenbaum, Lisa D Berman-Booty, et al.
Cell Cycle (Georgetown, Tex.)|June 12, 2012
Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone productionClaudia Capparelli, Carmela Guido, Diana Whitaker-Menezes, et al.
Molecular Cancer Research : MCR|October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell DeathSheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Pigment Cell & Melanoma Research|May 8, 2019
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated mannerDan A Erkes, Conroy O Field, Claudia Capparelli, et al.
Cell Cycle (Georgetown, Tex.)|June 12, 2012
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growthClaudia Capparelli, Diana Whitaker-Menezes, Carmela Guido, et al.
Cancer Research|August 18, 2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS MelanomaClaudia Capparelli, Timothy J Purwin, Shea A Heilman, et al.
Cell Cycle (Georgetown, Tex.)|September 1, 2012
CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesisClaudia Capparelli, Barbara Chiavarina, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|August 10, 2012
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate productionCarmela Guido, Diana Whitaker-Menezes, Claudia Capparelli, et al.
Molecular Cancer Therapeutics|June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant MelanomaMcKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Cell Cycle (Georgetown, Tex.)|December 2, 2011
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connectionRenee M Balliet, Claudia Capparelli, Carmela Guido, et al.
Cancer Research|July 25, 2015
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous MelanomasClaudia Capparelli, Sheera Rosenbaum, Lisa D Berman-Booty, et al.
Cell Cycle (Georgetown, Tex.)|June 12, 2012
Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone productionClaudia Capparelli, Carmela Guido, Diana Whitaker-Menezes, et al.
Molecular Cancer Research : MCR|October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell DeathSheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Pageof 3